New Vernon Capital Holdings Ii LLC Corcept Therapeutics Inc Transaction History

New Vernon Capital Holdings Ii LLC

  • $186 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 12, 2020
SELL
$12.06 - $16.96 $142,923 - $200,992
-11,851 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$10.41 - $14.66 $5,329 - $7,505
512 Added 4.52%
11,851 $168,000
Q2 2019

Aug 14, 2019
BUY
$9.78 - $12.76 $110,895 - $144,685
11,339 New
11,339 $126,000

Others Institutions Holding CORT

# of Institutions
368
Shares Held
86.8M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.29B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track New Vernon Capital Holdings Ii LLC Portfolio

Follow New Vernon Capital Holdings Ii LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Vernon Capital Holdings Ii LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Vernon Capital Holdings Ii LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email